frankw17

Author Archives

Tax-Free Oil Wealth

This is a request about an opinion re. ”Tax-Free Oil Wealth: The Perfect Retirement Plan” currently being pitched by Brian Hicks at Wealth Daily. He makes this thing sound like a phenomenal investment, tax free, that will make you incredibly wealthy. This reminds me of that old adage ”if it sounds to good to be […]

Tax-Free Oil Wealth

Travis, is a request about an opinion re. ”Tax-Free Oil Wealth: The Perfect Retirement Plan” currently being pitched by Brian Hicks at Wealth Daily. He makes this thing sound like a phenomenal investment, tax free, that will make you incredibly wealthy. This reminds me of that old adage ”if it sounds to good to be […]

Recent Author Comments

On Microblog: Gold, Silver, Copper, and Hard Assets…Fall 2017
HN, that was absolutely classic! You set us up with this paragraph: They say things like "The intercept penetrated a silicified cretacious gabbro sill that appears to be related to a magmatic plutonic intrusion from the Paleozoic era. that indicates sub-[...]
On Tear Sheet: CohBar Inc. ($CWBR)
NP; Ben, no one has mentioned it for awhile but you are an incredible ambassador to this thread on SG! Regards, Frank[...]
On Tear Sheet: CohBar Inc. ($CWBR)
Thanks Helen, it appears we are on the same page. Regards, Frank[...]
On Tear Sheet: CohBar Inc. ($CWBR)
Helen, thanks for your input re. leaps. I'm attempting to determine the cause of the problem. Is it due to the fact that a buyout could occur at a lower price than the price of the leap at a date well prior to the leap expiration, in which case the value[...]
On Tear Sheet: CohBar Inc. ($CWBR)
NP $ABEO; Abeona Therapeutics Inc. (NASDAQ:ABEO) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock. Previous closing price of $17.50 Regards, Frank[...]
On Tear Sheet: CohBar Inc. ($CWBR)
Long $AUPH; Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) is now covered by analysts at Seaport Global Securities. They set a "buy" rating and a $10.00 price target on the stock. 53.8% upside from the previous close of $6.50. Long $PTLA; Portola P[...]
On Tear Sheet: CohBar Inc. ($CWBR)
Long $CWBR, Glenn, I would like to add a huge amen to your post. The 2 gentlemen referred to are indeed an outstanding tandem! Thank you both for an outstanding CC. Regards, Frank[...]
On Cisco, Chang & Charlie Part 3
Dr. KSS, I bought into $AKBA shortly after you brought it to our attention. I sold half my initial purchase last week after it had doubled. Thanks to you I am now playing with house money! Regards, Frank[...]
On Cisco, Chang & Charlie Part 3
Long $ONOV. This appears to be positive news, but I'm surprised there's no activity in the stock after hours Regards, Frank[...]
On Cisco, Chang & Charlie Part 3
$XBI, Someone is getting very bullish on biotech. So far today, XBI has seen roughly 38,000 calls change hands -- more than four times the number of puts traded, and seven times the fund's average intraday call volume. XBI call volume is now pacing for th[...]
On Microblog: Gold, Silver, Copper, and Hard Assets…Fall 2017
$MAG; just saw this article from "Market Beat". 20 Stocks Wall Street Analysts Love the Most inShare MAG Silver Corp (NYSE:MAG) Consensus Rating: Buy Rating Score: 3.3 Ratings Breakdown: 7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings. Con[...]
On Cisco, Chang & Charlie Part 3
No ticker; everyone relax and grab another cup of java, it's "National Coffee Day". Regards, Frank[...]
On Cisco, Chang & Charlie Part 3
stm, no ticker. No, Schwab does not charge anything extra for penny stocks, except for a foreign stock charge in some cases. I bought a mining stock a few days ago whereby there were several thousand shares involved with a price of $.04 (thanks hn). The[...]
On Cisco, Chang & Charlie Part 3
Helen, $AXON,the options crowd is strongly negative with puts for 10/20/17 outnumbering calls by approximately a 3 to 2 ratio. Regards, Frank[...]
On Microblog: Gold, Silver, Copper, and Hard Assets…Fall 2017
hn, with these assets and projections, it's hard to believe $MUX is selling at $2.06 per share, barely off its yearly low at $1.98, which it touched yesterday. Long $MUX. Regards, Frank[...]
On Microblog: GOLD AND SILVER AND HARD ASSETS...SUMMER 2017
Hn, I would change that modifier from Neanderthal to "astute". Regards, Frank[...]
On Is Aurinia's Supremacy in Lupus Nephritis Threatened by Glaxo's Benlysta?
Jeffrey, I think you mean $PTGX do you not? Long $PTGX. Regards, Frank[...]
On Is Aurinia's Supremacy in Lupus Nephritis Threatened by Glaxo's Benlysta?
Ben, they are slamming the stock after hours. $TTOO is trading down 21% at $4.80. NP. Regards, Frank[...]
On Is Aurinia's Supremacy in Lupus Nephritis Threatened by Glaxo's Benlysta?
Helen, thank you. I can see where a company would want to negotiate from a position of strength. Hopefully that is the rationale in this case. Regards, Frank[...]
On Is Aurinia's Supremacy in Lupus Nephritis Threatened by Glaxo's Benlysta?
Dr. KSS, I hope you are "right on the money", but why would they have a stock offering if such a move was imminent? Long $PTLA. Regards, Frank[...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.